Human dendritic cells transfected with a human papilloma virus-18 construct display decreased mobility and upregulated cytokine production

Khaiboullina,Svetlana F.; Morzunov,Sergey P.; Hall,Mark R.; De Meirleir,Kenny L.; Rizvanov,Albert A.; Lombardi,Vincent C.

doi:10.3892/ijo.2013.2074

Human dendritic cells transfected with a human papilloma virus-18 construct display decreased mobility and upregulated cytokine production

Authors:
- Svetlana F. Khaiboullina
- Sergey P. Morzunov
- Mark R. Hall
- Kenny L. De Meirleir
- Albert A. Rizvanov
- Vincent C. Lombardi
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, University of Nevada, Reno, NV 89557, USA, Department of Microbiology, University of Nevada School of Medicine, Reno, NV 89557, USA, Human Physiology, Vrije Universiteit Brussel, Brussels, Belgium, Department of Genetics, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia
Published online on: August 21, 2013 https://doi.org/10.3892/ijo.2013.2074
Pages: 1701-1709

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The marked depletion of dendritic cells (DCs) in skin cancers, as well as preneoplastic and neoplastic cervical epithelium, suggests a central role for DCs in productive human papillomavirus (HPV) infection and cancer promotion. It has been suggested that HPV may facilitate tumor development by reducing DC density, contributing to a decrease in local immune surveillance. In this study, we have examined the response of human DCs transfected with a construct containing the HPV18 genome and their subsequent expression of papilloma virus proteins. Transfected cells expressed the L1 major capsid protein and upregulated E6 and E7 oncoprotein transcripts as detected by RT-PCR. Transfection of DCs also resulted in a significant increase in cytokine production. Finally, we observed that HPV18 transfection decreased the migratory activity of DCs. Our data indicate that HPV transfection of DCs leads to changes in migratory activity and cytokine production, which potentially can suppress or delay immune responses to viral antigens. Additionally, changes in cytokine production by HPV-transformed human fibroblasts and human cervical epithelial cells revealed that the migratory and antigen-presenting functions of DCs may be impaired by the suppressive effects of cytokines produced by HPV-infected epithelial and stromal cells.

View Figures

View References

1.	zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta. 1288:F55–F78. 1996.PubMed/NCBI
2.	Kanodia S, Fahey LM and Kast WM: Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets. 7:79–89. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Frazer IH: The role of the immune system in anogenital human papillomavirus. Australas J Dermatol. 39(Suppl 1): S5–S7. 1998.PubMed/NCBI
4.	al-Saleh W, Giannini SL, Jacobs N, et al: Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol. 184:283–290. 1998. View Article : Google Scholar
5.	Coleman N, Birley HD, Renton AM, et al: Immunological events in regressing genital warts. Am J Clin Pathol. 102:768–774. 1994.PubMed/NCBI
6.	al-Saleh W, Delvenne P, Arrese JE, Nikkels AF, Pierard GE and Boniver J: Inverse modulation of intraepithelial Langerhans’ cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch. 427:41–48. 1995.
7.	McArdle JP and Muller HK: Quantitative assessment of Langerhans’ cells in human cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol. 154:509–515. 1986.
8.	Morelli AE, Sananes C, Di Paola G, Paredes A and Fainboim L: Relationship between types of human papillomavirus and Langerhans’ cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol. 99:200–206. 1993.
9.	Morris HH, Gatter KC, Stein H and Mason DY: Langerhans’ cells in human cervical epithelium: an immunohistological study. Br J Obstet Gynaecol. 90:400–411. 1983.
10.	Viac J, Guerin-Reverchon I, Chardonnet Y and Bremond A: Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology. 180:328–338. 1990. View Article : Google Scholar
11.	Abbas AK, Lichtman AH and Pober JS: Cellular and Molecular Immunology. Saunders; Philadelphia, PA: 1997
12.	Breathnach SM: The Langerhans cell. Br J Dermatol. 119:463–469. 1988. View Article : Google Scholar
13.	Melief CJ: Dendritic cells as specialized antigen-presenting cells. Res Immunol. 140:902–906; discussion 918–926, 1989.
14.	Mota F, Rayment N, Chong S, Singer A and Chain B: The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol. 116:33–40. 1999. View Article : Google Scholar : PubMed/NCBI
15.	Hubert P, van den Brule F, Giannini SL, Franzen-Detrooz E, Boniver J and Delvenne P: Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol. 154:775–784. 1999. View Article : Google Scholar
16.	Arany I, Goel A and Tyring SK: Interferon response depends on viral transcription in human papillomavirus-containing lesions. Anticancer Res. 15:2865–2869. 1995.PubMed/NCBI
17.	Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE and Um SJ: Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem. 275:6764–6769. 2000. View Article : Google Scholar
18.	Evander M, Frazer IH, Payne E, Qi YM, Hengst K and McMillan NA: Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol. 71:2449–2456. 1997.PubMed/NCBI
19.	Price AA, Cumberbatch M, Kimber I and Ager A: Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med. 186:1725–1735. 1997. View Article : Google Scholar : PubMed/NCBI
20.	Bonnez W, Reichman RC, Strussenberg J and Roberts NJ Jr: In vitro interactions between bovine papillomavirus and human monocytes and macrophages. Intervirology. 32:246–252. 1991.PubMed/NCBI
21.	Tagami H, Oguchi M and Ofuji S: The phenomenon of spontaneous regression of numerous flat warts: immunohistological studies. Cancer. 45:2557–2563. 1980. View Article : Google Scholar : PubMed/NCBI
22.	Beutner KR and Tyring S: Human papillomavirus and human disease. Am J Med. 102:9–15. 1997. View Article : Google Scholar : PubMed/NCBI
23.	Shah KV and Howley PM: Papillomaviruses. Fields BN, Knipe DM and Howley M: Fields Virology. 3rd edition. Lippincott-Raven Publishers; Philadelphia, PA: pp. 2077–2109. 1996
24.	Le Buanec H, D’Anna R, Lachgar A, et al: HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomed Pharmacother. 53:424–431. 1999.
25.	Carter JJ, Koutsky LA, Hughes JP, et al: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis. 181:1911–1919. 2000. View Article : Google Scholar : PubMed/NCBI
26.	Lin YL, Borenstein LA, Selvakumar R, Ahmed R and Wettstein FO: Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J Virol. 67:382–389. 1993.PubMed/NCBI
27.	Park JS, Park DC, Kim CJ, et al: HPV-16-related proteins as the serologic markers in cervical neoplasia. Gynecol Oncol. 69:47–55. 1998. View Article : Google Scholar : PubMed/NCBI
28.	Steele JC and Gallimore PH: Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology. 174:388–398. 1990. View Article : Google Scholar : PubMed/NCBI
29.	Suzich JA, Ghim SJ, Palmer-Hill FJ, et al: Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA. 92:11553–11557. 1995. View Article : Google Scholar : PubMed/NCBI
30.	Frazer IH, Thomas R, Zhou J, et al: Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev. 168:131–142. 1999. View Article : Google Scholar : PubMed/NCBI
31.	Rosl F, Lengert M, Albrecht J, et al: Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol. 68:2142–2150. 1994.PubMed/NCBI
32.	Santin AD, Hermonat PL, Ravaggi A, et al: Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7 - pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol. 21:17–23. 2000.
33.	Carlson MW, Iyer VR and Marcotte EM: Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways. BMC Genomics. 8:1172007. View Article : Google Scholar : PubMed/NCBI
34.	Miyasaka M, Takami Y, Inoue H and Hakura A: Rat primary embryo fibroblast cells suppress transformation by the E6 and E7 genes of human papillomavirus type 16 in somatic hybrid cells. J Virol. 65:479–482. 1991.
35.	Yutsudo M, Okamoto Y and Hakura A: Functional dissociation of transforming genes of human papillomavirus type 16. Virology. 166:594–597. 1988. View Article : Google Scholar : PubMed/NCBI
36.	Cumberbatch M, Dearman RJ and Kimber I: Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology. 87:513–518. 1996. View Article : Google Scholar : PubMed/NCBI
37.	Saitoh A, Yasaka N, Osada A, Nakamura K, Furue M and Tamaki K: Migration of Langerhans cells in an in vitro organ culture system: IL-6 and TNF-alpha are partially responsible for migration into the epidermis. J Dermatol Sci. 19:166–174. 1999. View Article : Google Scholar : PubMed/NCBI
38.	Stoitzner P, Zanella M, Ortner U, et al: Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-alpha and IL-1beta. J Leukoc Biol. 66:462–470. 1999.PubMed/NCBI
39.	Hope JC, Cumberbatch M, Fielding I, Dearman RJ, Kimber I and Hopkins SJ: Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology. 86:441–447. 1995.PubMed/NCBI
40.	Gibran NS, Ferguson M, Heimbach DM and Isik FF: Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res. 70:1–6. 1997. View Article : Google Scholar : PubMed/NCBI
41.	Shreedhar V, Giese T, Sung VW and Ullrich SE: A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol. 160:3783–3789. 1998.PubMed/NCBI
42.	Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today. 13:265–270. 1992. View Article : Google Scholar : PubMed/NCBI
43.	Miller MD and Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol. 12:17–46. 1992.PubMed/NCBI
44.	Muller WA and Randolph GJ: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol. 66:698–704. 1999.PubMed/NCBI
45.	Kleine K, Konig G, Kreuzer J, Komitowski D, Zur Hausen H and Rosl F: The effect of the JE (MCP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic-cell hybrids in nude mice. Mol Carcinog. 14:179–189. 1995. View Article : Google Scholar : PubMed/NCBI
46.	Braun L, Durst M, Mikumo R, Crowley A and Robinson M: Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection. Mol Carcinog. 6:100–111. 1992. View Article : Google Scholar
47.	Ozbun MA and Meyers C: Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol. 70:5437–5446. 1996.PubMed/NCBI
48.	Borkowski TA, Letterio JJ, Farr AG and Udey MC: A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med. 184:2417–2422. 1996. View Article : Google Scholar : PubMed/NCBI
49.	Geissmann F, Prost C, Monnet JP, Dy M, Brousse N and Hermine O: Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med. 187:961–966. 1998. View Article : Google Scholar
50.	Sato K, Kawasaki H, Nagayama H, et al: TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol. 164:2285–2295. 2000. View Article : Google Scholar
51.	Strobl H and Knapp W: TGF-beta1 regulation of dendritic cells. Microbes Infect. 1:1283–1290. 1999. View Article : Google Scholar : PubMed/NCBI
52.	Nunez R, Sanchez M, Wild P, Filgueira L and Nunez C: Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunol Lett. 61:33–43. 1998. View Article : Google Scholar : PubMed/NCBI
53.	Cole ST and Danos O: Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol. 193:599–608. 1987. View Article : Google Scholar : PubMed/NCBI
54.	Dunzendorfer S, Kaser A, Meierhofer C, Tilg H and Wiedermann CJ: Dendritic cell migration in different micropore filter assays. Immunol Lett. 71:5–11. 2000. View Article : Google Scholar : PubMed/NCBI